Project Overview

Our IP strategy project was designed to help pharmaceutical companies protect and monetize intellectual property through sophisticated transfer pricing structures. When biotech companies develop valuable IP across multiple jurisdictions, they require expert valuation and licensing strategies that optimize returns while ensuring regulatory compliance.

Pharmaceutical IP represents unique transfer pricing challenges due to high development costs, uncertain outcomes, and significant value creation potential. Our specialized approach addresses industry-specific requirements while establishing defensible valuation methodologies that protect substantial R&D investments.

Challenges & Objectives

Before our comprehensive solution, the e-commerce platform faced mounting compliance pressure across rapidly expanding operations:

  • Unprotected IP Assets – Valuable research developments lacked proper transfer pricing structure, exposing €15M in R&D investments to potential value erosion.
  • Valuation Complexity – Difficulty establishing arm's length pricing for unique pharmaceutical compounds with limited comparable transactions.
  • Multi-Stage Development Risk – Complex development timeline from research through commercialization required sophisticated risk-sharing arrangements.
  • Regulatory Scrutiny – High-value IP transfers attract intense tax authority attention, requiring bulletproof documentation and economic justification.
Image

Our Approach

We implemented a comprehensive IP strategy combining advanced valuation techniques, risk assessment, and strategic licensing structures. Our methodology addressed the unique challenges of pharmaceutical development while establishing defensible transfer pricing positions.

We developed sophisticated valuation models incorporating development stage, commercial potential, and risk factors. This enabled creation of appropriate licensing arrangements that reflected actual value creation while distributing risks and returns according to functions performed and assets used.

Our documentation strategy included detailed economic analysis, functional assessment, and ongoing monitoring systems to ensure the IP structure remains compliant and defensible throughout the development and commercialization process.

Contact us
Icon
Icon

Final Thoughts

Our strategic IP framework successfully protected the €15M R&D investment while establishing optimal licensing structure for current and future intellectual property developments. The pharmaceutical company now operates with enhanced IP monetization capability and robust regulatory protection.

This case demonstrates how specialized transfer pricing expertise can protect and optimize pharmaceutical IP assets, ensuring maximum value realization while maintaining full compliance with complex regulatory requirements.

Developing valuable IP that needs protection? Contact us today for strategic valuation and licensing solutions that maximize your innovation investments!

Image

Our projects

See more of our work in action

View all projects
Icon
Icon

Tax office secured additional PLN 50,000 revenue by completing comprehensive tax project with our transfer pricing expertise, delivering complete solution in 10 days.

SaaS IT company avoided tax audit and secured 3-year compliance protection through comprehensive benchmarking analysis and updated transfer pricing documentation.

View all projects
Icon
Icon